Augmentation of Partial Anterior Cruciate Ligament Tear: Early Results (Augmentation)

December 17, 2025 updated by: Michael Mikhaeil Attallah Gendy, Assiut University
Clinical evaluation for the patients with partial ACL tear who had ACL augmentation

Study Overview

Detailed Description

we will do a clinical evaluation depending mainly on IKDC score for patients with partial ACL tear who undergoing ACL augmentation surgery inside Assiut university hospital

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Mohamed Abd-El Radi, Lecturer
  • Phone Number: 01225338766
  • Email: mradi@aun.edu.eg

Study Locations

      • Asyut, Egypt
        • Recruiting
        • Assiyt University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 50 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • age from 15 to 50 years old
  • Partial ACL tear without any other ligament injury
  • with and without meniscal tear
  • with and without knee deformity
  • recent and chronic injury

Exclusion Criteria:

  • younger than 15 and older than 50 y
  • multiligament injury
  • complete ACL tear
  • failed ACL reconstruction or repair

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Augmentation group
We will use hamstring graft in which fixation of graft will be by adjustable loop devices for femoral part fixation & Bioscrews +/- staples for tibial part fixation
we will do ACL augmentation surgery to the patients who have ACL partial tear using hamstring graft and fixation of the graft to the femoral part by adjustable loop and tibial part with Bio or peak screws +\- staples.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The main outcome is difference in IKDC scores between the patients
Time Frame: Baseline
we will evaluate the clinical outcome post operative mainly according to the difference in IKDC score between the patients
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Mohamed Abd-El Radi, Lecturer, Orthopaedic Department , Faculty of medicine, Assiut University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 9, 2022

Primary Completion (Estimated)

March 19, 2026

Study Completion (Estimated)

March 19, 2026

Study Registration Dates

First Submitted

May 21, 2022

First Submitted That Met QC Criteria

May 21, 2022

First Posted (Actual)

May 26, 2022

Study Record Updates

Last Update Posted (Actual)

December 22, 2025

Last Update Submitted That Met QC Criteria

December 17, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 17101888

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on ACL Injury

Clinical Trials on we will do ACL augmentation surgery to the patients who have partial ACL tear

Subscribe